Homologous recombination deficiency (HRD) scoring in pancreatic ductal adenocarcinoma (PDAC) and response to chemotherapy

被引:0
|
作者
O'Kane, Grainne M.
Denroche, Rob
Picardo, Sarah Louise
Zhang, Amy
Holter, Spring
Grant, Robert C.
Allen, Michael
Wang, Yifan
Dodd, Anna
Ramotar, Stephanie
Hutchinson, Shawn
Tehfe, Mustapha
Biagi, James Joseph
Wilson, Julie
Notta, Faiyaz
Fischer, Sandra
Zogopoulos, George
Gallinger, Steven
Knox, Jennifer J.
机构
[1] Princess Margaret Canc Ctr, Toronto, ON, Canada
[2] Ontario Inst Canc Res, Toronto, ON, Canada
[3] Beaumont Hosp, Dept Med Oncol, Dublin, Ireland
[4] Ontario Inst Canc Res, Toronto, ON, Canada
[5] Samuel Lunenfeld Res Inst, Toronto, ON, Canada
[6] Princess Margaret Canc Ctr, Div Med Oncol & Hematol, Toronto, ON, Canada
[7] McGill Univ, Montreal, PQ, Canada
[8] Univ Hlth Network, Princess Margaret Canc Ctr, Toronto, ON, Canada
[9] CHU Montreal, Hop Notre Dame, Montreal, PQ, Canada
[10] Queens Univ, Canc Ctr Southeastern Ontario, Kingston, ON, Canada
[11] Univ Hlth Network, Toronto Gen Hosp, Toronto, ON, Canada
[12] McGill Univ, Hlth Ctr, Montreal, PQ, Canada
[13] Toronto Gen Hosp, Toronto, ON, Canada
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
741
引用
收藏
页数:2
相关论文
共 50 条
  • [41] Comprehensive genomic analysis in metastatic pancreatic ductal adenocarcinoma (PDAC).
    Wong, Hui-Li
    Jones, Martin
    Eirew, Peter
    Karasinska, Joanna
    Schrader, Kasmintan A.
    Lim, Howard John
    Shen, Yaoqing
    Jones, Steven
    Yip, Stephen
    Laskin, Janessa J.
    Marra, Marco
    Schaeffer, David F.
    Renouf, Daniel John
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (04)
  • [42] Hereditary pancreatitis (HP) and the risk of pancreatic ductal adenocarcinoma (PDAC)
    Howes, N
    Lerch, MM
    Charnley, R
    Mössner, J
    Endres, S
    Deviere, J
    Verreman, V
    Lucidi, V
    Ohla, A
    Ihse, I
    Imrie, C
    Steenbergan, W
    Poll, A
    Greenhalf, W
    Ellis, I
    Mountford, R
    Whitcomb, DC
    Neoptolemos, JP
    GUT, 2002, 50 : A43 - A43
  • [43] Neuroplastic Changes in a Mouse Model of Pancreatic Ductal Adenocarcinoma (PDAC)
    Stopczynski, Rachelle E.
    DePinho, Ronald A.
    Ying, Haoqiang
    Schwartz, Erica S.
    Albers, Kathryn M.
    Davis, Brian M.
    Bielefeldt, Klaus
    GASTROENTEROLOGY, 2010, 138 (05) : S62 - S62
  • [44] Clinically impactful metabolic subtypes of pancreatic ductal adenocarcinoma (PDAC)
    Pervin, Jannat
    Asad, Mohammad
    Cao, Shaolong
    Jang, Gun Ho
    Feizi, Nikta
    Haibe-Kains, Benjamin
    Karasinska, Joanna M.
    O'Kane, Grainne M.
    Gallinger, Steven
    Schaeffer, David F.
    Renouf, Daniel J.
    Zogopoulos, George
    Bathe, Oliver F.
    FRONTIERS IN GENETICS, 2023, 14
  • [45] The microbiome as a potential diagnostic biomarker for pancreatic ductal adenocarcinoma (PDAC)
    Wheatley, Roseanna C.
    Valle, Juan W.
    McNamara, Mairead G.
    HEPATOBILIARY SURGERY AND NUTRITION, 2022,
  • [46] Vascular Resections for Pancreatic Ductal Adenocarcinoma: Vascular Resections for PDAC
    Oba, A.
    Bao, Q. R.
    Barnett, C. C.
    AI-Musawi, M. H.
    Croce, C.
    Schulick, R. D.
    Del Chiaro, M.
    SCANDINAVIAN JOURNAL OF SURGERY, 2020, 109 (01) : 18 - 28
  • [47] Genetic and other risk factors for pancreatic ductal adenocarcinoma (PDAC)
    Jacobs, Michelle F.
    Stoffel, Elena M.
    FAMILIAL CANCER, 2024, 23 (03) : 221 - 232
  • [48] Imaging p53 in Pancreatic Ductal Adenocarcinoma (PDAC)
    Koustoulidou, S.
    Knight, J. C.
    Kersemans, V.
    O'Neill, E.
    Cornelissen, B.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2016, 43 : S230 - S230
  • [49] Neoantigen-based immunotherapy in pancreatic ductal adenocarcinoma (PDAC)
    Chen, Hao
    Yang, Gang
    Xiao, Jianchun
    Zheng, Lianfang
    You, Lei
    Zhang, Taiping
    CANCER LETTERS, 2020, 490 : 12 - 19
  • [50] Exploring therapeutic strategies against pancreatic ductal adenocarcinoma (PDAC).
    Liaki, Vasiliki
    CANCER RESEARCH, 2021, 81 (22) : 58 - 59